Hepatitis C Treatment : Hepatitis C Re-Treatment Recommendations
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hep Newsletter
Join Us:
Lesson Hepatitis C Treatment

email

Hepatitis C Re-Treatment Recommendations

If you have been treated for HCV before, here are the recommendations for re-treatment for all genotypes from the American Association for the Study of Liver Diseases (AASLD) and Infectious Diseases Society of America (IDSA):

AASLD HCV Re-treatment Recommendations for Patients Who Failed Prior Peginterferon and Ribavirin Treatment
Recommended Alternative
Genotype 1a
(no cirrhosis)
Harvoni for 12 weeks
OR
Olysio + Sovaldi with/without
ribavirin for 12 weeks
OR
Viekira Pak + ribavirin for 12 weeks
n/a
Genotype 1a
(with compensated cirrhosis)
Harvoni for 24 weeks
OR
Harvoni + ribavirin for 12 weeks
OR
Olysio + Sovaldi with/without
ribavirin for 24 weeks
OR
Viekira Pak + ribavirin for 24 weeks
n/a
Genotype 1b
(no cirrhosis)
Harvoni for 12 weeks
OR
Olysio + Sovaldi with/without
ribavirin for 12 weeks
OR
Viekira Pak for 12 weeks
n/a
Genotype 1b
(with compensated cirrhosis)
Harvoni for 24 weeks
OR
Harvoni + ribavirin for 12 weeks
OR
Olysio + Sovaldi with/without
ribavirin for 24 weeks
OR
Viekira Pak + ribavirin for 12 weeks
n/a
Genotype 2 Sovaldi + ribavirin for 12 to 16 weeks Sovaldi + ribavirin + PEG** for 12 weeks
Genotype 3Sovaldi + ribavirin for 24 weeks Sovaldi + ribavirin + PEG** for 12 weeks
Genotype 4 Harvoni for 12 weeks
OR
Viekira Pak (without dasabuvir)
+ ribavirin for 12 weeks
OR
Sovaldi + ribavirin + PEG** for 12 weeks
OR
Sovaldi + ribavirin for 24 weeks
n/a
Genotype 5 Sovaldi + ribavirin + PEG** for 12 weeks PEG** + ribavirin for 48 weeks
Genotype 6 Harvoni for 12 weeks Sovaldi + ribavirin + PEG** for 12 weeks


AASLD HCV Re-treatment Recommendations for Patients Who Failed a Previous Sovaldi (sofosbuvir)-Containing Regimen
Recommended Alternative
Genotype 1
(no cirrhosis)
Defer further treatment, unless there is an urgent need to treat n/a
Genotype 1
(with cirrhosis)
Harvoni with/without ribavirin for 24 weeks n/a


AASLD HCV Re-treatment Recommendations for Patients Who Failed Prior Treatment with Peginterferon, Ribavirin, and an HCV Protease Inhibitor
Recommended Alternative
Genotype 1
(no cirrhosis)
Harvoni for 12 weeks none
Genotype 1
(with cirrhosis)
Harvoni without ribavirin for 24 weeks
OR
Harvoni with ribavirin for 12 weeks
n/a


* When more than one treatment is recommended, they are listed alphabetically
** PEG = peginterferon


back next




Search for news stories about this topic

Last Revised: January 12, 2015

This content is written by the Hep editorial team.

QUICK LINKS

Current Issue
Forums
Poll
Blogs
Hep Stories
Calendar
Services Directory
Conference News
Top Stories
Treatment News
Hep Exclusives
All About Hepatitis
• Hepatitis A
Transmission
Prevention
Treatment
• Hepatitis B
Transmission
Prevention
Treatment
• Hepatitis C
Transmission
Prevention
Treatment
HCV/HIV Coinfection
Help Paying For Meds
Clinical Trials
Lesson Index
Collapse All | Up One Level

© 2015 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.